# A Study to Evaluate the Bioavailability of BMS-986205

> **NCT03374228** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 7 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** BMS-986205

## Key facts

- **NCT ID:** NCT03374228
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-04
- **Primary completion:** 2018-02-16
- **Final completion:** 2018-02-16
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2018-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03374228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03374228, "A Study to Evaluate the Bioavailability of BMS-986205". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03374228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*